Cancer chemotherapy: mechanisms of action.
D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000145:classification; D001665:Binding Sites; D003561:Cytarabine / Q000627:therapeutic use; D004357:Drug Synergism; D057487:Enzyme Therapy; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D008466:Mechlorethamine / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000494:pharmacology; D008937:Mitomycins / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D009696:Nucleic Acids; D011687:Purines / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000037:antagonists & inhibitors; D013256:Steroids / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000470:Alkaloids; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D008937:Mitomycins; D009696:Nucleic Acids; D011687:Purines; D011743:Pyrimidines; D013256:Steroids; D003561:Cytarabine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D015122:Mercaptopurine; D013866:Thioguanine; D002955:Leucovorin; D006918:Hydroxyurea; D008727:Methotrexate